A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer

被引:0
|
作者
Haili Lu
Siluo Zha
Wei Zhang
Qiang Wang
Daozhen Jiang
Xinyun Xu
Xiangmin Zheng
Ming Qiu
Chengxiang Shan
机构
[1] Third Division of Department of General Surgery of Changzheng Hospital affiliated with Naval Military Medical University,
来源
BMC Cancer | / 21卷
关键词
Nab-paclitaxel; Metastatic breast cancer; Safety; Efficacy; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer
    Lu, Haili
    Zha, Siluo
    Zhang, Wei
    Wang, Qiang
    Jiang, Daozhen
    Xu, Xinyun
    Zheng, Xiangmin
    Qiu, Ming
    Shan, Chengxiang
    [J]. BMC CANCER, 2021, 21 (01)
  • [2] Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials
    Liu, Yun
    Ye, Guoxin
    Yan, Dali
    Zhang, Lei
    Fan, Fan
    Feng, Jifeng
    [J]. ONCOTARGET, 2017, 8 (42) : 72950 - 72958
  • [3] Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis
    Lee, Yoon Suk
    Lee, Jong-chan
    Kim, Jae-Hyeong
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis
    Yoon Suk Lee
    Jong-chan Lee
    Jae-Hyeong Kim
    Jaihwan Kim
    Jin-Hyeok Hwang
    [J]. Scientific Reports, 11
  • [5] Efficacy and safety of nab-paclitaxel in metastatic gastric cancer: a meta-analysis
    Ahmad, Suhana
    Lambuk, Lidawani
    Ahmed, Naveed
    Mussa, Ali
    Tee, Vincent
    Idris, Ros Akmal Mohd
    Sahran, Nur Fazimah
    Chan, Yean Yean
    Hassan, Rosline
    Lee, Yeong Yeh
    Mohamud, Rohimah
    [J]. NANOMEDICINE, 2023, 18 (24) : 1733 - 1744
  • [6] nab-Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer
    Glueck, Stefan
    [J]. CLINICAL BREAST CANCER, 2014, 14 (04) : 221 - 227
  • [7] Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
    Miao Liu
    Siyao Liu
    Liu Yang
    Shu Wang
    [J]. BMC Cancer, 21
  • [8] Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
    Liu, Miao
    Liu, Siyao
    Yang, Liu
    Wang, Shu
    [J]. BMC CANCER, 2021, 21 (01)
  • [9] Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Pusceddu, Sara
    Ghidini, Michele
    Torchio, Martina
    Corti, Francesca
    Tomasello, Gianluca
    Niger, Monica
    Prinzi, Natalie
    Nichetti, Federico
    Coinu, Andrea
    Di Bartolomeo, Maria
    Cabiddu, Mary
    Passalacqua, Rodolfo
    de Braud, Filippo
    Petrelli, Fausto
    [J]. CANCERS, 2019, 11 (04)
  • [10] Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis
    Li, Yong
    Lu, Xiaoju
    Lin, Qimou
    Li, Weiwen
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)